Novel motif:33: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:40, 9 September 2013
name: | motif33_AGAGCATGAGACGG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0043503 | skeletal muscle fiber adaptation | 6.913463e-14 |
GO:0007512 | adult heart development | 3.680037e-11 |
GO:0007522 | visceral muscle development | 1.511833e-10 |
GO:0051926 | negative regulation of calcium ion transport | 5.040475e-10 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 2.330233e-9 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 3.143481e-8 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 4.013657e-8 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.393481e-7 |
GO:0051856 | adhesion to symbiont | 1.452303e-7 |
GO:0001941 | postsynaptic membrane organization | 5.122897e-7 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 5.177030e-7 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 5.223339e-7 |
GO:0032793 | positive regulation of CREB transcription factor activity | 6.249947e-7 |
GO:0046314 | phosphocreatine biosynthetic process | 6.588383e-7 |
GO:0050434 | positive regulation of viral transcription | 7.324090e-7 |
GO:0014002 | astrocyte development | 7.679792e-7 |
GO:0032526 | response to retinoic acid | 8.044195e-7 |
GO:0071732 | cellular response to nitric oxide | 8.199230e-7 |
GO:0010529 | negative regulation of transposition | 1.085057e-6 |
GO:0015816 | glycine transport | 1.140546e-6 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 1.351251e-6 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 1.641966e-6 |
GO:0010765 | positive regulation of sodium ion transport | 1.643584e-6 |
GO:0052697 | xenobiotic glucuronidation | 2.008429e-6 |
GO:0070980 | biphenyl catabolic process | 2.008429e-6 |
GO:0051552 | flavone metabolic process | 2.008429e-6 |
GO:0006789 | bilirubin conjugation | 2.008429e-6 |
GO:0052696 | flavonoid glucuronidation | 2.008429e-6 |
GO:0045618 | positive regulation of keratinocyte differentiation | 2.013209e-6 |
GO:0042396 | phosphagen biosynthetic process | 2.013209e-6 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 2.433130e-6 |
GO:0048845 | venous blood vessel morphogenesis | 3.631581e-6 |
GO:0000375 | RNA splicing, via transesterification reactions | 3.696598e-6 |
GO:0042637 | catagen | 4.169246e-6 |
GO:0006032 | chitin catabolic process | 4.245100e-6 |
GO:0034447 | very-low-density lipoprotein particle clearance | 4.374926e-6 |
GO:0046730 | induction of host immune response by virus | 4.771657e-6 |
GO:0035883 | enteroendocrine cell differentiation | 5.023887e-6 |
GO:0001974 | blood vessel remodeling | 5.052381e-6 |
GO:0010984 | regulation of lipoprotein particle clearance | 5.335879e-6 |
GO:0010625 | positive regulation of Schwann cell proliferation | 5.617632e-6 |
GO:0034616 | response to laminar fluid shear stress | 5.869955e-6 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 7.856858e-6 |
GO:0045606 | positive regulation of epidermal cell differentiation | 7.856858e-6 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 9.049313e-6 |
GO:0060539 | diaphragm development | 1.016441e-5 |
GO:0060743 | epithelial cell maturation involved in prostate gland development | 1.189632e-5 |
GO:0060841 | venous blood vessel development | 1.373266e-5 |
GO:0032717 | negative regulation of interleukin-8 production | 1.377513e-5 |
GO:0071731 | response to nitric oxide | 1.455290e-5 |
GO:0060421 | positive regulation of heart growth | 1.605685e-5 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.628800e-5 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 1.655526e-5 |
GO:0046782 | regulation of viral transcription | 1.715575e-5 |
GO:0033239 | negative regulation of cellular amine metabolic process | 2.006064e-5 |
GO:0021603 | cranial nerve formation | 2.408848e-5 |
GO:0043501 | skeletal muscle adaptation | 2.441941e-5 |
GO:0021569 | rhombomere 3 development | 2.640563e-5 |
GO:0048075 | positive regulation of eye pigmentation | 2.649096e-5 |
GO:0072668 | tubulin complex biogenesis | 2.709089e-5 |
GO:0034766 | negative regulation of ion transmembrane transport | 2.780566e-5 |
GO:0014888 | striated muscle adaptation | 2.815948e-5 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 2.924880e-5 |
GO:0009312 | oligosaccharide biosynthetic process | 2.950854e-5 |
GO:0071584 | negative regulation of zinc ion import | 3.373145e-5 |
GO:0090281 | negative regulation of calcium ion import | 3.373145e-5 |
GO:0001909 | leukocyte mediated cytotoxicity | 3.749186e-5 |
GO:0035850 | epithelial cell differentiation involved in kidney development | 3.749420e-5 |
GO:0046732 | active induction of host immune response by virus | 3.780059e-5 |
GO:0010226 | response to lithium ion | 3.857291e-5 |
GO:0060124 | positive regulation of growth hormone secretion | 4.133469e-5 |
GO:0090141 | positive regulation of mitochondrial fission | 4.549166e-5 |
GO:0001886 | endothelial cell morphogenesis | 4.623186e-5 |
GO:0006370 | mRNA capping | 4.629319e-5 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 4.706398e-5 |
GO:0002712 | regulation of B cell mediated immunity | 4.888756e-5 |
GO:0045575 | basophil activation | 4.968750e-5 |
GO:0001694 | histamine biosynthetic process | 4.968750e-5 |
GO:0022617 | extracellular matrix disassembly | 5.280635e-5 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 5.415113e-5 |
GO:0010897 | negative regulation of triglyceride catabolic process | 5.415113e-5 |
GO:0009452 | RNA capping | 5.581548e-5 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 5.708317e-5 |
GO:0003219 | cardiac right ventricle formation | 6.288804e-5 |
GO:0045838 | positive regulation of membrane potential | 6.594695e-5 |
GO:0007140 | male meiosis | 6.864997e-5 |
GO:0046856 | phosphatidylinositol dephosphorylation | 7.193190e-5 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 7.481020e-5 |
GO:0071474 | cellular hyperosmotic response | 7.481020e-5 |
GO:0006352 | transcription initiation, DNA-dependent | 7.527652e-5 |
GO:2000001 | regulation of DNA damage checkpoint | 7.579116e-5 |
GO:0071874 | cellular response to norepinephrine stimulus | 7.873742e-5 |
GO:0071407 | cellular response to organic cyclic compound | 7.985493e-5 |
GO:0051013 | microtubule severing | 8.385198e-5 |
GO:0006706 | steroid catabolic process | 8.482659e-5 |
GO:0048524 | positive regulation of viral reproduction | 8.703962e-5 |
GO:0032656 | regulation of interleukin-13 production | 8.919889e-5 |
GO:0008617 | guanosine metabolic process | 8.933279e-5 |
GO:0060997 | dendritic spine morphogenesis | 8.934521e-5 |
GO:0045843 | negative regulation of striated muscle tissue development | 9.222653e-5 |
GO:0061302 | smooth muscle cell-matrix adhesion | 9.496181e-5 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 9.496181e-5 |
GO:0050792 | regulation of viral reproduction | 9.510336e-5 |
GO:0002467 | germinal center formation | 1.015521e-4 |
GO:0046839 | phospholipid dephosphorylation | 1.125756e-4 |
GO:0032375 | negative regulation of cholesterol transport | 1.125756e-4 |
GO:0051890 | regulation of cardioblast differentiation | 1.126736e-4 |
GO:0045085 | negative regulation of interleukin-2 biosynthetic process | 1.149458e-4 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 1.207162e-4 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.218611e-4 |
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 1.299488e-4 |
GO:0050975 | sensory perception of touch | 1.398047e-4 |
GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis | 1.518085e-4 |
GO:0034340 | response to type I interferon | 1.546870e-4 |
GO:0006449 | regulation of translational termination | 1.563500e-4 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 1.584310e-4 |
GO:0033326 | cerebrospinal fluid secretion | 1.615065e-4 |
GO:0010923 | negative regulation of phosphatase activity | 1.657577e-4 |
GO:0010936 | negative regulation of macrophage cytokine production | 1.700222e-4 |
GO:0034436 | glycoprotein transport | 1.700926e-4 |
GO:0009720 | detection of hormone stimulus | 1.700926e-4 |
GO:0070309 | lens fiber cell morphogenesis | 1.717394e-4 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 1.798289e-4 |
GO:0060337 | type I interferon-mediated signaling pathway | 1.800696e-4 |
GO:0021546 | rhombomere development | 1.856946e-4 |
GO:0043380 | regulation of memory T cell differentiation | 1.904177e-4 |
GO:0060020 | Bergmann glial cell differentiation | 1.936764e-4 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.994443e-4 |
GO:0045940 | positive regulation of steroid metabolic process | 2.137029e-4 |
GO:0007141 | male meiosis I | 2.165483e-4 |
GO:0000387 | spliceosomal snRNP assembly | 2.204320e-4 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 2.258096e-4 |
GO:0007356 | thorax and anterior abdomen determination | 2.258096e-4 |
GO:0070508 | cholesterol import | 2.271993e-4 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 2.412216e-4 |
GO:0043243 | positive regulation of protein complex disassembly | 2.448387e-4 |
GO:0003329 | pancreatic PP cell fate commitment | 2.495465e-4 |
GO:0003326 | pancreatic A cell fate commitment | 2.495465e-4 |
GO:0014733 | regulation of skeletal muscle adaptation | 2.501384e-4 |
GO:0035066 | positive regulation of histone acetylation | 2.525409e-4 |
GO:0060123 | regulation of growth hormone secretion | 2.680460e-4 |
GO:0072321 | chaperone-mediated protein transport | 2.783765e-4 |
GO:0060996 | dendritic spine development | 2.831017e-4 |
GO:0048708 | astrocyte differentiation | 3.043090e-4 |
GO:0015804 | neutral amino acid transport | 3.119927e-4 |
GO:0007007 | inner mitochondrial membrane organization | 3.194676e-4 |
GO:0019062 | virion attachment to host cell surface receptor | 3.325721e-4 |
GO:0045039 | protein import into mitochondrial inner membrane | 3.339449e-4 |
GO:0048486 | parasympathetic nervous system development | 3.340338e-4 |
GO:0006379 | mRNA cleavage | 3.392059e-4 |
GO:0014057 | positive regulation of acetylcholine secretion | 3.426953e-4 |
GO:0045819 | positive regulation of glycogen catabolic process | 3.594945e-4 |
GO:0097113 | alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering | 3.737078e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 3.737078e-4 |
GO:0010893 | positive regulation of steroid biosynthetic process | 3.787675e-4 |
GO:0007109 | cytokinesis, completion of separation | 3.790789e-4 |
GO:0032425 | positive regulation of mismatch repair | 3.842166e-4 |
GO:0007585 | respiratory gaseous exchange | 3.846024e-4 |
GO:0046684 | response to pyrethroid | 3.896805e-4 |
GO:0045191 | regulation of isotype switching | 3.997988e-4 |
GO:0001885 | endothelial cell development | 4.669329e-4 |
GO:0060712 | spongiotrophoblast layer development | 4.764043e-4 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 4.769266e-4 |
GO:0035871 | protein K11-linked deubiquitination | 4.923289e-4 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 4.953239e-4 |
GO:0046814 | virion attachment, binding of host cell surface coreceptor | 4.973352e-4 |
GO:0032472 | Golgi calcium ion transport | 4.973352e-4 |
GO:0030026 | cellular manganese ion homeostasis | 4.973352e-4 |
GO:0032468 | Golgi calcium ion homeostasis | 4.973352e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 5.094367e-4 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 5.190649e-4 |
GO:0097120 | receptor localization to synapse | 5.267963e-4 |
GO:0032736 | positive regulation of interleukin-13 production | 5.267963e-4 |
GO:0072578 | neurotransmitter-gated ion channel clustering | 5.267963e-4 |
GO:0070831 | basement membrane assembly | 5.295850e-4 |
GO:0018205 | peptidyl-lysine modification | 5.374838e-4 |
GO:0048073 | regulation of eye pigmentation | 5.460843e-4 |
GO:0008292 | acetylcholine biosynthetic process | 5.460843e-4 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 5.682803e-4 |
GO:0035461 | vitamin transmembrane transport | 5.754579e-4 |
GO:0000414 | regulation of histone H3-K36 methylation | 5.810736e-4 |
GO:0005993 | trehalose catabolic process | 5.884622e-4 |
GO:0070179 | D-serine biosynthetic process | 5.888737e-4 |
GO:0051793 | medium-chain fatty acid catabolic process | 5.888737e-4 |
GO:0033189 | response to vitamin A | 6.025040e-4 |
GO:0003264 | regulation of cardioblast proliferation | 6.092063e-4 |
GO:0018879 | biphenyl metabolic process | 6.180223e-4 |
GO:0055099 | response to high density lipoprotein particle stimulus | 6.214573e-4 |
GO:0034405 | response to fluid shear stress | 6.258543e-4 |
GO:0061005 | cell differentiation involved in kidney development | 6.488494e-4 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 6.586158e-4 |
GO:0002070 | epithelial cell maturation | 6.825323e-4 |
GO:0035305 | negative regulation of dephosphorylation | 6.852095e-4 |
GO:0007271 | synaptic transmission, cholinergic | 7.132929e-4 |
GO:0071681 | cellular response to indole-3-methanol | 7.157375e-4 |
GO:0009311 | oligosaccharide metabolic process | 7.211044e-4 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 7.350286e-4 |
GO:0042723 | thiamine-containing compound metabolic process | 7.382432e-4 |
GO:0006353 | transcription termination, DNA-dependent | 7.449819e-4 |
GO:0050689 | negative regulation of defense response to virus by host | 7.547508e-4 |
GO:0048143 | astrocyte activation | 7.594845e-4 |
GO:0002028 | regulation of sodium ion transport | 7.617324e-4 |
GO:0045589 | regulation of regulatory T cell differentiation | 7.639142e-4 |
GO:0033578 | protein glycosylation in Golgi | 7.639142e-4 |
GO:0043491 | protein kinase B signaling cascade | 7.703580e-4 |
GO:0045830 | positive regulation of isotype switching | 7.867707e-4 |
GO:0008380 | RNA splicing | 7.897267e-4 |
GO:0045446 | endothelial cell differentiation | 7.939513e-4 |
GO:0006285 | base-excision repair, AP site formation | 7.988586e-4 |
GO:0072166 | posterior mesonephric tubule development | 8.007828e-4 |
GO:0003230 | cardiac atrium development | 8.479464e-4 |
GO:0048642 | negative regulation of skeletal muscle tissue development | 8.629655e-4 |
GO:0048771 | tissue remodeling | 8.673304e-4 |
GO:0051702 | interaction with symbiont | 8.689684e-4 |
GO:0006540 | glutamate decarboxylation to succinate | 8.699504e-4 |
GO:0006417 | regulation of translation | 8.727245e-4 |
GO:0051177 | meiotic sister chromatid cohesion | 8.752427e-4 |
GO:0017004 | cytochrome complex assembly | 8.891945e-4 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 8.891945e-4 |
GO:0010034 | response to acetate | 8.926745e-4 |
GO:0045590 | negative regulation of regulatory T cell differentiation | 8.926745e-4 |
GO:0061307 | cardiac neural crest cell differentiation involved in heart development | 8.988920e-4 |
GO:0072112 | glomerular visceral epithelial cell differentiation | 9.203905e-4 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 9.207107e-4 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 9.472343e-4 |
GO:0002071 | glandular epithelial cell maturation | 9.633688e-4 |
GO:0006701 | progesterone biosynthetic process | 9.836188e-4 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 1.018842e-3 |
GO:0001575 | globoside metabolic process | 1.024318e-3 |
GO:0035752 | lysosomal lumen pH elevation | 1.024318e-3 |
GO:0000046 | autophagic vacuole fusion | 1.024318e-3 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 1.024981e-3 |
GO:0003158 | endothelium development | 1.035194e-3 |
GO:0010872 | regulation of cholesterol esterification | 1.040615e-3 |
GO:0072194 | kidney smooth muscle tissue development | 1.051841e-3 |
GO:0034959 | endothelin maturation | 1.051841e-3 |
GO:0010814 | substance P catabolic process | 1.051841e-3 |
GO:0010816 | calcitonin catabolic process | 1.051841e-3 |
GO:0002064 | epithelial cell development | 1.082535e-3 |
GO:0006772 | thiamine metabolic process | 1.089680e-3 |
GO:0046070 | dGTP metabolic process | 1.111927e-3 |
GO:0045726 | positive regulation of integrin biosynthetic process | 1.111927e-3 |
GO:0000920 | cytokinetic cell separation | 1.111927e-3 |
GO:0033344 | cholesterol efflux | 1.117159e-3 |
GO:0007266 | Rho protein signal transduction | 1.128356e-3 |
GO:0051764 | actin crosslink formation | 1.135775e-3 |
GO:0042117 | monocyte activation | 1.153180e-3 |
GO:0010452 | histone H3-K36 methylation | 1.154344e-3 |
GO:0032835 | glomerulus development | 1.209111e-3 |
GO:0006884 | cell volume homeostasis | 1.212495e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 1.258740e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 1.259922e-3 |
GO:0071316 | cellular response to nicotine | 1.289835e-3 |
GO:0000089 | mitotic metaphase | 1.293766e-3 |
GO:0045076 | regulation of interleukin-2 biosynthetic process | 1.322011e-3 |
GO:0045008 | depyrimidination | 1.325444e-3 |
GO:0021612 | facial nerve structural organization | 1.331818e-3 |
GO:0015734 | taurine transport | 1.334109e-3 |
GO:0061032 | visceral serous pericardium development | 1.334109e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.334109e-3 |
GO:0048210 | Golgi vesicle fusion to target membrane | 1.334109e-3 |
GO:0010693 | negative regulation of alkaline phosphatase activity | 1.345847e-3 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.356012e-3 |
GO:0019064 | viral envelope fusion with host membrane | 1.356598e-3 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.359748e-3 |
GO:0043149 | stress fiber assembly | 1.363812e-3 |
GO:0048477 | oogenesis | 1.403664e-3 |
GO:0070625 | zymogen granule exocytosis | 1.433254e-3 |
GO:0090149 | membrane fission involved in mitochondrial fission | 1.433254e-3 |
GO:0014895 | smooth muscle hypertrophy | 1.433254e-3 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 1.433254e-3 |
GO:0002082 | regulation of oxidative phosphorylation | 1.433254e-3 |
GO:0003374 | dynamin polymerization involved in mitochondrial fission | 1.433254e-3 |
GO:0006026 | aminoglycan catabolic process | 1.434974e-3 |
GO:0090140 | regulation of mitochondrial fission | 1.439272e-3 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 1.440633e-3 |
GO:0042942 | D-serine transport | 1.443785e-3 |
GO:0007023 | post-chaperonin tubulin folding pathway | 1.468640e-3 |
GO:0032836 | glomerular basement membrane development | 1.478207e-3 |
GO:0006828 | manganese ion transport | 1.518454e-3 |
GO:0070383 | DNA cytosine deamination | 1.555684e-3 |
GO:0021570 | rhombomere 4 development | 1.555684e-3 |
GO:0032423 | regulation of mismatch repair | 1.608287e-3 |
GO:0002513 | tolerance induction to self antigen | 1.620943e-3 |
GO:0001826 | inner cell mass cell differentiation | 1.672100e-3 |
GO:0060252 | positive regulation of glial cell proliferation | 1.695704e-3 |
GO:0043586 | tongue development | 1.723811e-3 |
GO:0043382 | positive regulation of memory T cell differentiation | 1.731457e-3 |
GO:0016188 | synaptic vesicle maturation | 1.743047e-3 |
GO:0071585 | detoxification of cadmium ion | 1.747531e-3 |
GO:0070946 | neutrophil mediated killing of gram-positive bacterium | 1.747531e-3 |
GO:0002703 | regulation of leukocyte mediated immunity | 1.780671e-3 |
GO:0051569 | regulation of histone H3-K4 methylation | 1.795840e-3 |
GO:0072075 | metanephric mesenchyme development | 1.807399e-3 |
GO:0003382 | epithelial cell morphogenesis | 1.827302e-3 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1.845584e-3 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 1.888805e-3 |
GO:0070483 | detection of hypoxia | 1.918881e-3 |
GO:0090324 | negative regulation of oxidative phosphorylation | 1.920258e-3 |
GO:0010255 | glucose mediated signaling pathway | 1.920258e-3 |
GO:0070873 | regulation of glycogen metabolic process | 1.932957e-3 |
GO:0030302 | deoxynucleotide transport | 1.939584e-3 |
GO:0009804 | coumarin metabolic process | 1.939584e-3 |
GO:0034384 | high-density lipoprotein particle clearance | 1.963465e-3 |
GO:0016559 | peroxisome fission | 1.977001e-3 |
GO:0071280 | cellular response to copper ion | 1.977001e-3 |
GO:0070294 | renal sodium ion absorption | 1.983627e-3 |
GO:0070875 | positive regulation of glycogen metabolic process | 1.989558e-3 |
GO:0060126 | somatotropin secreting cell differentiation | 2.000814e-3 |
GO:0002026 | regulation of the force of heart contraction | 2.010251e-3 |
GO:0006354 | transcription elongation, DNA-dependent | 2.028665e-3 |
GO:0006244 | pyrimidine nucleotide catabolic process | 2.031724e-3 |
GO:0072195 | kidney smooth muscle cell differentiation | 2.040095e-3 |
GO:0072105 | ureteric peristalsis | 2.040095e-3 |
GO:0051668 | localization within membrane | 2.048298e-3 |
GO:2000543 | positive regulation of gastrulation | 2.057981e-3 |
GO:0046622 | positive regulation of organ growth | 2.099171e-3 |
GO:0070734 | histone H3-K27 methylation | 2.117562e-3 |
GO:0006707 | cholesterol catabolic process | 2.144382e-3 |
GO:0021783 | preganglionic parasympathetic nervous system development | 2.145072e-3 |
GO:0050720 | interleukin-1 beta biosynthetic process | 2.156936e-3 |
GO:0021599 | abducens nerve formation | 2.156936e-3 |
GO:0061090 | positive regulation of sequestering of zinc ion | 2.156936e-3 |
GO:0016191 | synaptic vesicle uncoating | 2.156936e-3 |
GO:0007634 | optokinetic behavior | 2.156936e-3 |
GO:0043538 | regulation of actin phosphorylation | 2.201802e-3 |
GO:0051089 | constitutive protein ectodomain proteolysis | 2.201802e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 2.201802e-3 |
GO:0007285 | primary spermatocyte growth | 2.201802e-3 |
GO:0055005 | ventricular cardiac myofibril development | 2.210650e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 2.238427e-3 |
GO:0021571 | rhombomere 5 development | 2.273560e-3 |
GO:0033119 | negative regulation of RNA splicing | 2.279252e-3 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 2.299448e-3 |
GO:0042267 | natural killer cell mediated cytotoxicity | 2.321380e-3 |
GO:0016078 | tRNA catabolic process | 2.345041e-3 |
GO:0007198 | inhibition of adenylate cyclase activity by serotonin receptor signaling pathway | 2.345041e-3 |
GO:0001682 | tRNA 5'-leader removal | 2.345041e-3 |
GO:0090128 | regulation of synapse maturation | 2.370170e-3 |
GO:0043462 | regulation of ATPase activity | 2.370618e-3 |
GO:0048148 | behavioral response to cocaine | 2.435274e-3 |
GO:0003136 | negative regulation of heart induction by canonical Wnt receptor signaling pathway | 2.481348e-3 |
GO:0006538 | glutamate catabolic process | 2.543156e-3 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 2.543156e-3 |
GO:0002238 | response to molecule of fungal origin | 2.637500e-3 |
GO:0070943 | neutrophil mediated killing of symbiont cell | 2.665074e-3 |
GO:0042760 | very long-chain fatty acid catabolic process | 2.665074e-3 |
GO:0050652 | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 2.667085e-3 |
GO:0042167 | heme catabolic process | 2.741601e-3 |
GO:0051927 | negative regulation of calcium ion transport via voltage-gated calcium channel activity | 2.838465e-3 |
GO:0018023 | peptidyl-lysine trimethylation | 2.840730e-3 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 2.852015e-3 |
GO:0060973 | cell migration involved in heart development | 2.857453e-3 |
GO:0045351 | type I interferon biosynthetic process | 2.857453e-3 |
GO:0072189 | ureter development | 2.887514e-3 |
GO:0010692 | regulation of alkaline phosphatase activity | 2.887514e-3 |
GO:0043932 | ossification involved in bone remodeling | 2.972132e-3 |
GO:0006054 | N-acetylneuraminate metabolic process | 2.976169e-3 |
GO:0001807 | regulation of type IV hypersensitivity | 2.976169e-3 |
GO:0071108 | protein K48-linked deubiquitination | 2.981945e-3 |
GO:0032202 | telomere assembly | 3.013168e-3 |
GO:0090129 | positive regulation of synapse maturation | 3.013168e-3 |
GO:0010536 | positive regulation of activation of Janus kinase activity | 3.013168e-3 |
GO:0003266 | regulation of secondary heart field cardioblast proliferation | 3.013168e-3 |
GO:0003417 | growth plate cartilage development | 3.029047e-3 |
GO:0048320 | axial mesoderm formation | 3.063748e-3 |
GO:0046683 | response to organophosphorus | 3.086953e-3 |
GO:0051148 | negative regulation of muscle cell differentiation | 3.114657e-3 |
GO:0060837 | blood vessel endothelial cell differentiation | 3.124417e-3 |
GO:0034776 | response to histamine | 3.124417e-3 |
GO:0030902 | hindbrain development | 3.138428e-3 |
GO:0071236 | cellular response to antibiotic | 3.188091e-3 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 3.203095e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 3.226986e-3 |
GO:0030852 | regulation of granulocyte differentiation | 3.242352e-3 |
GO:0042398 | cellular modified amino acid biosynthetic process | 3.243106e-3 |
GO:0018022 | peptidyl-lysine methylation | 3.316305e-3 |
GO:0060177 | regulation of angiotensin metabolic process | 3.316305e-3 |
GO:0045066 | regulatory T cell differentiation | 3.319351e-3 |
GO:0006473 | protein acetylation | 3.361874e-3 |
GO:0070857 | regulation of bile acid biosynthetic process | 3.396262e-3 |
GO:2000109 | regulation of macrophage apoptosis | 3.398814e-3 |
GO:0003209 | cardiac atrium morphogenesis | 3.403045e-3 |
GO:0032606 | type I interferon production | 3.416951e-3 |
GO:0018963 | phthalate metabolic process | 3.416951e-3 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 3.429337e-3 |
GO:0034330 | cell junction organization | 3.433856e-3 |
GO:0017148 | negative regulation of translation | 3.479504e-3 |
GO:0035303 | regulation of dephosphorylation | 3.485039e-3 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 3.594404e-3 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 3.594404e-3 |
GO:0045006 | DNA deamination | 3.594404e-3 |
GO:0050765 | negative regulation of phagocytosis | 3.642059e-3 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 3.834965e-3 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 3.834965e-3 |
GO:0030433 | ER-associated protein catabolic process | 3.911780e-3 |
GO:0010621 | negative regulation of transcription by transcription factor localization | 3.979547e-3 |
GO:0070141 | response to UV-A | 3.982000e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 4.006755e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 4.006755e-3 |
GO:0003014 | renal system process | 4.026496e-3 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 4.029683e-3 |
GO:0032411 | positive regulation of transporter activity | 4.051627e-3 |
GO:0035499 | carnosine biosynthetic process | 4.079413e-3 |
GO:0016242 | negative regulation of macroautophagy | 4.079413e-3 |
GO:0003181 | atrioventricular valve morphogenesis | 4.096366e-3 |
GO:0016579 | protein deubiquitination | 4.099455e-3 |
GO:0035815 | positive regulation of renal sodium excretion | 4.108597e-3 |
GO:0000578 | embryonic axis specification | 4.123439e-3 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 4.150009e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 4.156241e-3 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 4.207632e-3 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 4.259077e-3 |
GO:0045175 | basal protein localization | 4.259950e-3 |
GO:0051665 | membrane raft localization | 4.352178e-3 |
GO:0030826 | regulation of cGMP biosynthetic process | 4.403529e-3 |
GO:0045901 | positive regulation of translational elongation | 4.411030e-3 |
GO:0045905 | positive regulation of translational termination | 4.411030e-3 |
GO:0006452 | translational frameshifting | 4.411030e-3 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 4.512348e-3 |
GO:0014056 | regulation of acetylcholine secretion | 4.515986e-3 |
GO:0009298 | GDP-mannose biosynthetic process | 4.568692e-3 |
GO:0015788 | UDP-N-acetylglucosamine transport | 4.583766e-3 |
GO:0006474 | N-terminal protein amino acid acetylation | 4.592420e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 4.655796e-3 |
GO:0048635 | negative regulation of muscle organ development | 4.665526e-3 |
GO:0045109 | intermediate filament organization | 4.746300e-3 |
GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway | 4.782948e-3 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 4.804168e-3 |
GO:0035284 | brain segmentation | 4.804168e-3 |
GO:0000090 | mitotic anaphase | 4.840026e-3 |
GO:0002002 | regulation of angiotensin levels in blood | 4.887063e-3 |
GO:0051152 | positive regulation of smooth muscle cell differentiation | 4.945820e-3 |
GO:0060426 | lung vasculature development | 4.981798e-3 |
GO:0070345 | negative regulation of fat cell proliferation | 5.011701e-3 |
GO:0050890 | cognition | 5.019527e-3 |
GO:0060319 | primitive erythrocyte differentiation | 5.058599e-3 |
GO:0002575 | basophil chemotaxis | 5.058599e-3 |
GO:0016137 | glycoside metabolic process | 5.137797e-3 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 5.137797e-3 |
GO:2000209 | regulation of anoikis | 5.223571e-3 |
GO:0007379 | segment specification | 5.278669e-3 |
GO:0045911 | positive regulation of DNA recombination | 5.339097e-3 |
GO:0032792 | negative regulation of CREB transcription factor activity | 5.343431e-3 |
GO:0035710 | CD4-positive, alpha-beta T cell activation | 5.394395e-3 |
GO:0032506 | cytokinetic process | 5.420482e-3 |
GO:0043500 | muscle adaptation | 5.435416e-3 |
GO:0016264 | gap junction assembly | 5.439509e-3 |
GO:0045368 | positive regulation of interleukin-13 biosynthetic process | 5.472934e-3 |
GO:0021610 | facial nerve morphogenesis | 5.550879e-3 |
GO:0003416 | endochondral bone growth | 5.555208e-3 |
GO:0007021 | tubulin complex assembly | 5.604347e-3 |
GO:0050764 | regulation of phagocytosis | 5.758947e-3 |
GO:0042472 | inner ear morphogenesis | 5.830366e-3 |
GO:0090103 | cochlea morphogenesis | 5.888282e-3 |
GO:0033146 | regulation of estrogen receptor signaling pathway | 5.925525e-3 |
GO:2001014 | regulation of skeletal muscle cell differentiation | 5.931059e-3 |
GO:0071318 | cellular response to ATP | 6.117569e-3 |
GO:0009404 | toxin metabolic process | 6.216079e-3 |
GO:0019852 | L-ascorbic acid metabolic process | 6.236581e-3 |
GO:0019747 | regulation of isoprenoid metabolic process | 6.253382e-3 |
GO:0002457 | T cell antigen processing and presentation | 6.253382e-3 |
GO:0010477 | response to sulfur dioxide | 6.253382e-3 |
GO:0051902 | negative regulation of mitochondrial depolarization | 6.272365e-3 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 6.335080e-3 |
GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 6.347473e-3 |
GO:0032957 | inositol trisphosphate metabolic process | 6.376593e-3 |
GO:0033003 | regulation of mast cell activation | 6.392088e-3 |
GO:0070858 | negative regulation of bile acid biosynthetic process | 6.402894e-3 |
GO:0002250 | adaptive immune response | 6.508647e-3 |
GO:0001773 | myeloid dendritic cell activation | 6.514091e-3 |
GO:0060561 | apoptosis involved in morphogenesis | 6.544956e-3 |
GO:0006700 | C21-steroid hormone biosynthetic process | 6.558275e-3 |
GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway | 6.566479e-3 |
GO:0048488 | synaptic vesicle endocytosis | 6.567598e-3 |
GO:0042104 | positive regulation of activated T cell proliferation | 6.612582e-3 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 6.735458e-3 |
GO:0071105 | response to interleukin-11 | 6.735458e-3 |
GO:0006713 | glucocorticoid catabolic process | 6.735458e-3 |
GO:0090370 | negative regulation of cholesterol efflux | 6.829920e-3 |
GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain | 6.829920e-3 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 6.829920e-3 |
GO:0032119 | sequestering of zinc ion | 6.829920e-3 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 6.856553e-3 |
GO:0043049 | otic placode formation | 6.873120e-3 |
GO:0030432 | peristalsis | 6.873120e-3 |
GO:0043543 | protein acylation | 6.877800e-3 |
GO:0045113 | regulation of integrin biosynthetic process | 6.906297e-3 |
GO:0003310 | pancreatic A cell differentiation | 7.005715e-3 |
GO:0006546 | glycine catabolic process | 7.090473e-3 |
GO:0035712 | T-helper 2 cell activation | 7.091560e-3 |
GO:2000525 | positive regulation of T cell costimulation | 7.091560e-3 |
GO:0071954 | chemokine (C-C motif) ligand 11 production | 7.091560e-3 |
GO:0035709 | memory T cell activation | 7.091560e-3 |
GO:0002215 | defense response to nematode | 7.091560e-3 |
GO:0015878 | biotin transport | 7.091560e-3 |
GO:0015887 | pantothenate transmembrane transport | 7.091560e-3 |
GO:0035708 | interleukin-4-dependent isotype switching to IgE isotypes | 7.091560e-3 |
GO:0060977 | coronary vasculature morphogenesis | 7.113678e-3 |
GO:0042178 | xenobiotic catabolic process | 7.138425e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0070646 | protein modification by small protein removal | 1.390297e-12 |
GO:0016579 | protein deubiquitination | 1.211142e-11 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.637368e-9 |
GO:0003229 | ventricular cardiac muscle tissue development | 6.772919e-9 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 1.245005e-8 |
GO:0007522 | visceral muscle development | 1.270237e-7 |
GO:0003230 | cardiac atrium development | 2.135292e-7 |
GO:0060696 | regulation of phospholipid catabolic process | 3.472141e-7 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 5.469414e-7 |
GO:0048340 | paraxial mesoderm morphogenesis | 6.143414e-7 |
GO:0030509 | BMP signaling pathway | 7.486412e-7 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.248226e-6 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.330562e-6 |
GO:0042254 | ribosome biogenesis | 1.874243e-6 |
GO:0015780 | nucleotide-sugar transport | 1.953789e-6 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.964725e-6 |
GO:0016072 | rRNA metabolic process | 3.327351e-6 |
GO:0033143 | regulation of steroid hormone receptor signaling pathway | 3.385052e-6 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 5.207825e-6 |
GO:0009303 | rRNA transcription | 5.501647e-6 |
GO:0048532 | anatomical structure arrangement | 5.895322e-6 |
GO:0060012 | synaptic transmission, glycinergic | 6.214341e-6 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 6.419702e-6 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 6.705467e-6 |
GO:0022417 | protein maturation by protein folding | 6.705467e-6 |
GO:0006941 | striated muscle contraction | 1.089093e-5 |
GO:0045833 | negative regulation of lipid metabolic process | 1.449332e-5 |
GO:0030049 | muscle filament sliding | 1.481797e-5 |
GO:0006364 | rRNA processing | 1.492977e-5 |
GO:0003209 | cardiac atrium morphogenesis | 1.521205e-5 |
GO:0048339 | paraxial mesoderm development | 1.559548e-5 |
GO:2000657 | negative regulation of apolipoprotein binding | 1.708131e-5 |
GO:0006409 | tRNA export from nucleus | 1.708131e-5 |
GO:0014853 | regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction | 1.708131e-5 |
GO:0042476 | odontogenesis | 2.097871e-5 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 2.173698e-5 |
GO:0032288 | myelin assembly | 2.326565e-5 |
GO:0018924 | mandelate metabolic process | 2.357456e-5 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.421735e-5 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 2.694377e-5 |
GO:0035621 | ER to Golgi ceramide transport | 2.694377e-5 |
GO:0032218 | riboflavin transport | 2.694377e-5 |
GO:0043462 | regulation of ATPase activity | 2.989305e-5 |
GO:2000736 | regulation of stem cell differentiation | 3.093897e-5 |
GO:0009081 | branched chain family amino acid metabolic process | 3.162727e-5 |
GO:0070647 | protein modification by small protein conjugation or removal | 4.317887e-5 |
GO:0043558 | regulation of translational initiation in response to stress | 4.353940e-5 |
GO:0048739 | cardiac muscle fiber development | 4.410883e-5 |
GO:0045806 | negative regulation of endocytosis | 4.561636e-5 |
GO:0050665 | hydrogen peroxide biosynthetic process | 6.055915e-5 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 6.083025e-5 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 6.083025e-5 |
GO:0043555 | regulation of translation in response to stress | 6.322944e-5 |
GO:0032328 | alanine transport | 6.373952e-5 |
GO:0048352 | paraxial mesoderm structural organization | 6.697511e-5 |
GO:0021998 | neural plate mediolateral regionalization | 6.697511e-5 |
GO:0008334 | histone mRNA metabolic process | 7.203484e-5 |
GO:0060033 | anatomical structure regression | 7.761476e-5 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 7.905598e-5 |
GO:0015669 | gas transport | 7.927451e-5 |
GO:0045872 | positive regulation of rhodopsin gene expression | 8.196572e-5 |
GO:0043252 | sodium-independent organic anion transport | 8.196572e-5 |
GO:0043243 | positive regulation of protein complex disassembly | 8.566928e-5 |
GO:0070079 | histone H4-R3 demethylation | 8.765870e-5 |
GO:0070078 | histone H3-R2 demethylation | 8.765870e-5 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 8.765870e-5 |
GO:0023035 | CD40 signaling pathway | 8.765870e-5 |
GO:0021603 | cranial nerve formation | 9.162379e-5 |
GO:0021943 | formation of radial glial scaffolds | 9.278874e-5 |
GO:0003093 | regulation of glomerular filtration | 9.973252e-5 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 1.015711e-4 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.031926e-4 |
GO:0009083 | branched chain family amino acid catabolic process | 1.044251e-4 |
GO:0071104 | response to interleukin-9 | 1.064045e-4 |
GO:0044062 | regulation of excretion | 1.087756e-4 |
GO:0055008 | cardiac muscle tissue morphogenesis | 1.114664e-4 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 1.117336e-4 |
GO:0033129 | positive regulation of histone phosphorylation | 1.124194e-4 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 1.184225e-4 |
GO:0018205 | peptidyl-lysine modification | 1.328354e-4 |
GO:0097039 | protein linear polyubiquitination | 1.374518e-4 |
GO:0030913 | paranodal junction assembly | 1.378741e-4 |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 1.442543e-4 |
GO:0051004 | regulation of lipoprotein lipase activity | 1.491195e-4 |
GO:0000460 | maturation of 5.8S rRNA | 1.536289e-4 |
GO:0008366 | axon ensheathment | 1.687363e-4 |
GO:0001964 | startle response | 1.745044e-4 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.763803e-4 |
GO:0045793 | positive regulation of cell size | 1.884725e-4 |
GO:0046784 | intronless viral mRNA export from host nucleus | 1.917896e-4 |
GO:0060541 | respiratory system development | 1.987873e-4 |
GO:0006401 | RNA catabolic process | 2.050860e-4 |
GO:0003218 | cardiac left ventricle formation | 2.051423e-4 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.054493e-4 |
GO:0042508 | tyrosine phosphorylation of Stat1 protein | 2.139949e-4 |
GO:0032287 | peripheral nervous system myelin maintenance | 2.173047e-4 |
GO:2000739 | regulation of mesenchymal stem cell differentiation | 2.195270e-4 |
GO:0022613 | ribonucleoprotein complex biogenesis | 2.214438e-4 |
GO:0045040 | protein import into mitochondrial outer membrane | 2.276733e-4 |
GO:0071294 | cellular response to zinc ion | 2.282027e-4 |
GO:0071397 | cellular response to cholesterol | 2.291000e-4 |
GO:0071529 | cementum mineralization | 2.299089e-4 |
GO:0006449 | regulation of translational termination | 2.299089e-4 |
GO:0009889 | regulation of biosynthetic process | 2.317317e-4 |
GO:0060039 | pericardium development | 2.342210e-4 |
GO:0031326 | regulation of cellular biosynthetic process | 2.353020e-4 |
GO:0001880 | Mullerian duct regression | 2.353271e-4 |
GO:0010724 | regulation of definitive erythrocyte differentiation | 2.353271e-4 |
GO:0070172 | positive regulation of tooth mineralization | 2.391453e-4 |
GO:0032774 | RNA biosynthetic process | 2.467155e-4 |
GO:0072086 | specification of loop of Henle identity | 2.495269e-4 |
GO:0031323 | regulation of cellular metabolic process | 2.568478e-4 |
GO:0006351 | transcription, DNA-dependent | 2.605916e-4 |
GO:0034382 | chylomicron remnant clearance | 2.724175e-4 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 2.748139e-4 |
GO:0016568 | chromatin modification | 3.004806e-4 |
GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation | 3.051374e-4 |
GO:0071711 | basement membrane organization | 3.148844e-4 |
GO:0009082 | branched chain family amino acid biosynthetic process | 3.148844e-4 |
GO:0071843 | cellular component biogenesis at cellular level | 3.285600e-4 |
GO:0007260 | tyrosine phosphorylation of STAT protein | 3.448058e-4 |
GO:0021570 | rhombomere 4 development | 3.535585e-4 |
GO:0001977 | renal system process involved in regulation of blood volume | 3.575509e-4 |
GO:0006398 | histone mRNA 3'-end processing | 3.593137e-4 |
GO:0035441 | cell migration involved in vasculogenesis | 3.593137e-4 |
GO:0051171 | regulation of nitrogen compound metabolic process | 3.595939e-4 |
GO:0031117 | positive regulation of microtubule depolymerization | 3.654486e-4 |
GO:2000426 | negative regulation of apoptotic cell clearance | 3.725987e-4 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3.725987e-4 |
GO:0048291 | isotype switching to IgG isotypes | 3.933047e-4 |
GO:0071048 | nuclear retention of unspliced pre-mRNA at the site of transcription | 3.933047e-4 |
GO:0071035 | nuclear polyadenylation-dependent rRNA catabolic process | 3.933047e-4 |
GO:0002368 | B cell cytokine production | 3.933047e-4 |
GO:0002731 | negative regulation of dendritic cell cytokine production | 3.933047e-4 |
GO:0045221 | negative regulation of FasL biosynthetic process | 3.933047e-4 |
GO:0006308 | DNA catabolic process | 4.034817e-4 |
GO:0045922 | negative regulation of fatty acid metabolic process | 4.075286e-4 |
GO:0032900 | negative regulation of neurotrophin production | 4.114441e-4 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 4.114441e-4 |
GO:0032244 | positive regulation of nucleoside transport | 4.114441e-4 |
GO:0014057 | positive regulation of acetylcholine secretion | 4.114441e-4 |
GO:0010045 | response to nickel ion | 4.114441e-4 |
GO:0035815 | positive regulation of renal sodium excretion | 4.132584e-4 |
GO:0060415 | muscle tissue morphogenesis | 4.196443e-4 |
GO:0060192 | negative regulation of lipase activity | 4.327352e-4 |
GO:0016070 | RNA metabolic process | 4.374038e-4 |
GO:0044332 | Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 4.518121e-4 |
GO:0010501 | RNA secondary structure unwinding | 4.518121e-4 |
GO:0030262 | apoptotic nuclear change | 4.568192e-4 |
GO:0060760 | positive regulation of response to cytokine stimulus | 4.594364e-4 |
GO:0060026 | convergent extension | 4.695767e-4 |
GO:0043622 | cortical microtubule organization | 4.712722e-4 |
GO:0030103 | vasopressin secretion | 4.712722e-4 |
GO:0007231 | osmosensory signaling pathway | 4.712722e-4 |
GO:0070936 | protein K48-linked ubiquitination | 4.768991e-4 |
GO:0007379 | segment specification | 4.959444e-4 |
GO:0006473 | protein acetylation | 5.003893e-4 |
GO:0042552 | myelination | 5.129499e-4 |
GO:0000302 | response to reactive oxygen species | 5.151327e-4 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 5.210214e-4 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 5.210214e-4 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 5.286192e-4 |
GO:0050684 | regulation of mRNA processing | 5.633094e-4 |
GO:0008612 | peptidyl-lysine modification to hypusine | 5.682109e-4 |
GO:0048596 | embryonic camera-type eye morphogenesis | 5.707773e-4 |
GO:0060765 | regulation of androgen receptor signaling pathway | 5.764207e-4 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 5.811756e-4 |
GO:0003409 | optic cup structural organization | 5.814557e-4 |
GO:0021623 | oculomotor nerve formation | 5.814557e-4 |
GO:0003404 | optic vesicle morphogenesis | 5.814557e-4 |
GO:0007029 | endoplasmic reticulum organization | 6.166308e-4 |
GO:0007405 | neuroblast proliferation | 6.285553e-4 |
GO:0006325 | chromatin organization | 6.891723e-4 |
GO:0050995 | negative regulation of lipid catabolic process | 7.008902e-4 |
GO:0016570 | histone modification | 7.194781e-4 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 7.422199e-4 |
GO:0021773 | striatal medium spiny neuron differentiation | 7.532907e-4 |
GO:0010656 | negative regulation of muscle cell apoptosis | 8.007185e-4 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 8.150651e-4 |
GO:0006936 | muscle contraction | 8.183067e-4 |
GO:0003334 | keratinocyte development | 8.186846e-4 |
GO:0032663 | regulation of interleukin-2 production | 8.269208e-4 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 8.453187e-4 |
GO:0031947 | negative regulation of glucocorticoid biosynthetic process | 8.453187e-4 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 8.501008e-4 |
GO:0051084 | 'de novo' posttranslational protein folding | 8.573848e-4 |
GO:0015671 | oxygen transport | 8.739202e-4 |
GO:0032365 | intracellular lipid transport | 8.762809e-4 |
GO:0051099 | positive regulation of binding | 8.828152e-4 |
GO:0006551 | leucine metabolic process | 8.832559e-4 |
GO:0071281 | cellular response to iron ion | 8.846647e-4 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 8.846647e-4 |
GO:0021932 | hindbrain radial glia guided cell migration | 8.927740e-4 |
GO:0001963 | synaptic transmission, dopaminergic | 9.103062e-4 |
GO:0045905 | positive regulation of translational termination | 9.113978e-4 |
GO:0006452 | translational frameshifting | 9.113978e-4 |
GO:0045901 | positive regulation of translational elongation | 9.113978e-4 |
GO:0045843 | negative regulation of striated muscle tissue development | 9.356067e-4 |
GO:0003012 | muscle system process | 9.437330e-4 |
GO:0016569 | covalent chromatin modification | 9.471467e-4 |
GO:0048341 | paraxial mesoderm formation | 9.741535e-4 |
GO:0070170 | regulation of tooth mineralization | 9.879074e-4 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 1.028036e-3 |
GO:0080090 | regulation of primary metabolic process | 1.048199e-3 |
GO:0048644 | muscle organ morphogenesis | 1.066215e-3 |
GO:0010556 | regulation of macromolecule biosynthetic process | 1.066747e-3 |
GO:2000164 | negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | 1.076786e-3 |
GO:2000166 | negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | 1.076786e-3 |
GO:2000168 | negative regulation of planar cell polarity pathway involved in neural tube closure | 1.076786e-3 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 1.076786e-3 |
GO:2000162 | negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | 1.076786e-3 |
GO:2000055 | positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.076786e-3 |
GO:0097107 | postsynaptic density assembly | 1.076786e-3 |
GO:2000151 | negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 1.076786e-3 |
GO:2000149 | negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | 1.076786e-3 |
GO:0061310 | canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | 1.076786e-3 |
GO:0070194 | synaptonemal complex disassembly | 1.123203e-3 |
GO:0002730 | regulation of dendritic cell cytokine production | 1.123203e-3 |
GO:0006402 | mRNA catabolic process | 1.143896e-3 |
GO:0035813 | regulation of renal sodium excretion | 1.175735e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.175735e-3 |
GO:0021604 | cranial nerve structural organization | 1.237017e-3 |
GO:0021904 | dorsal/ventral neural tube patterning | 1.255573e-3 |
GO:0071034 | CUT catabolic process | 1.277531e-3 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 1.277531e-3 |
GO:0018394 | peptidyl-lysine acetylation | 1.300303e-3 |
GO:0002027 | regulation of heart rate | 1.301443e-3 |
GO:0015808 | L-alanine transport | 1.311386e-3 |
GO:0046881 | positive regulation of follicle-stimulating hormone secretion | 1.390183e-3 |
GO:0019369 | arachidonic acid metabolic process | 1.413706e-3 |
GO:0031959 | mineralocorticoid receptor signaling pathway | 1.432868e-3 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 1.446616e-3 |
GO:0070252 | actin-mediated cell contraction | 1.448386e-3 |
GO:0090304 | nucleic acid metabolic process | 1.449014e-3 |
GO:0071845 | cellular component disassembly at cellular level | 1.509742e-3 |
GO:0010725 | regulation of primitive erythrocyte differentiation | 1.549888e-3 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 1.549888e-3 |
GO:0034505 | tooth mineralization | 1.551411e-3 |
GO:0021861 | forebrain radial glial cell differentiation | 1.610775e-3 |
GO:0033146 | regulation of estrogen receptor signaling pathway | 1.631732e-3 |
GO:0051590 | positive regulation of neurotransmitter transport | 1.648789e-3 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 1.648789e-3 |
GO:0043353 | enucleate erythrocyte differentiation | 1.652513e-3 |
GO:0061143 | alveolar primary septum development | 1.655955e-3 |
GO:0031076 | embryonic camera-type eye development | 1.667853e-3 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.745327e-3 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.750197e-3 |
GO:0060428 | lung epithelium development | 1.756822e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.793423e-3 |
GO:0019751 | polyol metabolic process | 1.867888e-3 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.872583e-3 |
GO:0002830 | positive regulation of type 2 immune response | 1.880941e-3 |
GO:0006690 | icosanoid metabolic process | 1.882781e-3 |
GO:0043921 | modulation by host of viral transcription | 1.887726e-3 |
GO:0043633 | polyadenylation-dependent RNA catabolic process | 1.949999e-3 |
GO:0034276 | kynurenic acid biosynthetic process | 1.949999e-3 |
GO:0002534 | cytokine production involved in inflammatory response | 1.949999e-3 |
GO:0032924 | activin receptor signaling pathway | 1.985990e-3 |
GO:0030851 | granulocyte differentiation | 2.001971e-3 |
GO:0090245 | axis elongation involved in somitogenesis | 2.006651e-3 |
GO:0021874 | Wnt receptor signaling pathway involved in forebrain neuroblast division | 2.006651e-3 |
GO:0061036 | positive regulation of cartilage development | 2.025685e-3 |
GO:0060040 | retinal bipolar neuron differentiation | 2.036591e-3 |
GO:0051013 | microtubule severing | 2.036591e-3 |
GO:0046782 | regulation of viral transcription | 2.038515e-3 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 2.045929e-3 |
GO:0071333 | cellular response to glucose stimulus | 2.065759e-3 |
GO:0051481 | reduction of cytosolic calcium ion concentration | 2.077754e-3 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 2.083494e-3 |
GO:0033148 | positive regulation of estrogen receptor signaling pathway | 2.106918e-3 |
GO:0033235 | positive regulation of protein sumoylation | 2.139516e-3 |
GO:0006937 | regulation of muscle contraction | 2.151006e-3 |
GO:0071476 | cellular hypotonic response | 2.154536e-3 |
GO:0009880 | embryonic pattern specification | 2.155969e-3 |
GO:0045908 | negative regulation of vasodilation | 2.208422e-3 |
GO:0045819 | positive regulation of glycogen catabolic process | 2.208422e-3 |
GO:0030324 | lung development | 2.211975e-3 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 2.236103e-3 |
GO:0072321 | chaperone-mediated protein transport | 2.236103e-3 |
GO:0009950 | dorsal/ventral axis specification | 2.237484e-3 |
GO:0048048 | embryonic eye morphogenesis | 2.244715e-3 |
GO:0022411 | cellular component disassembly | 2.311387e-3 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 2.323374e-3 |
GO:0000738 | DNA catabolic process, exonucleolytic | 2.375498e-3 |
GO:0006921 | cellular component disassembly involved in apoptosis | 2.382005e-3 |
GO:0032693 | negative regulation of interleukin-10 production | 2.443825e-3 |
GO:0048635 | negative regulation of muscle organ development | 2.448573e-3 |
GO:0072070 | loop of Henle development | 2.476141e-3 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 2.488340e-3 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 2.531785e-3 |
GO:0032416 | negative regulation of sodium:hydrogen antiporter activity | 2.531785e-3 |
GO:0030323 | respiratory tube development | 2.572619e-3 |
GO:0032928 | regulation of superoxide anion generation | 2.666663e-3 |
GO:0060973 | cell migration involved in heart development | 2.741199e-3 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 2.748491e-3 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 2.922078e-3 |
GO:0042977 | activation of JAK2 kinase activity | 2.932533e-3 |
GO:0033275 | actin-myosin filament sliding | 2.936729e-3 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 2.970574e-3 |
GO:0019226 | transmission of nerve impulse | 2.975011e-3 |
GO:0046580 | negative regulation of Ras protein signal transduction | 2.979287e-3 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 2.982447e-3 |
GO:0070723 | response to cholesterol | 3.033949e-3 |
GO:0090231 | regulation of spindle checkpoint | 3.053844e-3 |
GO:0035641 | locomotory exploration behavior | 3.110343e-3 |
GO:0035409 | histone H3-Y41 phosphorylation | 3.159069e-3 |
GO:0008636 | activation of caspase activity by protein phosphorylation | 3.159069e-3 |
GO:0032239 | regulation of nucleobase-containing compound transport | 3.166514e-3 |
GO:0042554 | superoxide anion generation | 3.223565e-3 |
GO:0072210 | metanephric nephron development | 3.242153e-3 |
GO:0090102 | cochlea development | 3.253197e-3 |
GO:0006968 | cellular defense response | 3.278155e-3 |
GO:0021535 | cell migration in hindbrain | 3.343917e-3 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 3.371564e-3 |
GO:0021785 | branchiomotor neuron axon guidance | 3.371564e-3 |
GO:0071322 | cellular response to carbohydrate stimulus | 3.376569e-3 |
GO:0048747 | muscle fiber development | 3.435098e-3 |
GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change | 3.478834e-3 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 3.478834e-3 |
GO:0001973 | adenosine receptor signaling pathway | 3.497003e-3 |
GO:0010225 | response to UV-C | 3.513105e-3 |
GO:0006403 | RNA localization | 3.517168e-3 |
GO:0006546 | glycine catabolic process | 3.545383e-3 |
GO:0060399 | positive regulation of growth hormone receptor signaling pathway | 3.574929e-3 |
GO:0072015 | glomerular visceral epithelial cell development | 3.576848e-3 |
GO:0014029 | neural crest formation | 3.576848e-3 |
GO:0072081 | specification of nephron tubule identity | 3.839957e-3 |
GO:0002339 | B cell selection | 3.839957e-3 |
GO:0061153 | trachea gland development | 3.839957e-3 |
GO:0010035 | response to inorganic substance | 3.995376e-3 |
GO:0061205 | paramesonephric duct development | 4.007018e-3 |
GO:0043388 | positive regulation of DNA binding | 4.042711e-3 |
GO:0019376 | galactolipid catabolic process | 4.076460e-3 |
GO:0043543 | protein acylation | 4.097863e-3 |
GO:0043044 | ATP-dependent chromatin remodeling | 4.120237e-3 |
GO:0072014 | proximal tubule development | 4.127063e-3 |
GO:0006342 | chromatin silencing | 4.224737e-3 |
GO:0051891 | positive regulation of cardioblast differentiation | 4.329262e-3 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 4.518062e-3 |
GO:0006288 | base-excision repair, DNA ligation | 4.518062e-3 |
GO:0006940 | regulation of smooth muscle contraction | 4.525135e-3 |
GO:0006338 | chromatin remodeling | 4.528845e-3 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 4.533106e-3 |
GO:0006654 | phosphatidic acid biosynthetic process | 4.634073e-3 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 4.641763e-3 |
GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 4.732238e-3 |
GO:0060164 | regulation of timing of neuron differentiation | 4.907834e-3 |
GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 4.929578e-3 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 4.957778e-3 |
GO:0050689 | negative regulation of defense response to virus by host | 4.984869e-3 |
GO:0042512 | negative regulation of tyrosine phosphorylation of Stat1 protein | 4.984869e-3 |
GO:0048593 | camera-type eye morphogenesis | 5.006537e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 5.017098e-3 |
GO:0006475 | internal protein amino acid acetylation | 5.036243e-3 |
GO:0002579 | positive regulation of antigen processing and presentation | 5.061599e-3 |
GO:0060029 | convergent extension involved in organogenesis | 5.062349e-3 |
GO:0016075 | rRNA catabolic process | 5.078962e-3 |
GO:0034720 | histone H3-K4 demethylation | 5.078962e-3 |
GO:0010595 | positive regulation of endothelial cell migration | 5.152504e-3 |
GO:0008635 | activation of caspase activity by cytochrome c | 5.201064e-3 |
GO:0018279 | protein N-linked glycosylation via asparagine | 5.240255e-3 |
GO:0090257 | regulation of muscle system process | 5.368060e-3 |
GO:0006289 | nucleotide-excision repair | 5.407104e-3 |
GO:0060325 | face morphogenesis | 5.471368e-3 |
GO:0043966 | histone H3 acetylation | 5.471675e-3 |
GO:0030223 | neutrophil differentiation | 5.509194e-3 |
GO:0021557 | oculomotor nerve development | 5.509194e-3 |
GO:0034421 | post-translational protein acetylation | 5.538820e-3 |
GO:0045110 | intermediate filament bundle assembly | 5.538820e-3 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 5.538820e-3 |
GO:0060032 | notochord regression | 5.561061e-3 |
GO:0048382 | mesendoderm development | 5.561061e-3 |
GO:0051586 | positive regulation of dopamine uptake | 5.561061e-3 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 5.562645e-3 |
GO:0090274 | positive regulation of somatostatin secretion | 5.646817e-3 |
GO:0071028 | nuclear mRNA surveillance | 5.646817e-3 |
GO:2000706 | negative regulation of dense core granule biogenesis | 5.646817e-3 |
GO:2000798 | negative regulation of amniotic stem cell differentiation | 5.646817e-3 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 5.646817e-3 |
GO:0048047 | mating behavior, sex discrimination | 5.646817e-3 |
GO:0002124 | territorial aggressive behavior | 5.646817e-3 |
GO:0043538 | regulation of actin phosphorylation | 5.646817e-3 |
GO:0043312 | neutrophil degranulation | 5.680138e-3 |
GO:0050882 | voluntary musculoskeletal movement | 5.687334e-3 |
GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 5.687334e-3 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 5.687334e-3 |
GO:0022007 | convergent extension involved in neural plate elongation | 5.687334e-3 |
GO:0002175 | protein localization to paranode region of axon | 5.687334e-3 |
GO:0003208 | cardiac ventricle morphogenesis | 5.687819e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 5.812189e-3 |
GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 5.813389e-3 |
GO:0051252 | regulation of RNA metabolic process | 5.819332e-3 |
GO:0035887 | aortic smooth muscle cell differentiation | 5.996232e-3 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 6.001522e-3 |
GO:0042989 | sequestering of actin monomers | 6.039654e-3 |
GO:0045814 | negative regulation of gene expression, epigenetic | 6.319949e-3 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 6.336144e-3 |
GO:0071895 | odontoblast differentiation | 6.340862e-3 |
GO:0032222 | regulation of synaptic transmission, cholinergic | 6.340862e-3 |
GO:0009247 | glycolipid biosynthetic process | 6.388557e-3 |
GO:0044265 | cellular macromolecule catabolic process | 6.398529e-3 |
GO:0060235 | lens induction in camera-type eye | 6.442880e-3 |
GO:0016573 | histone acetylation | 6.457998e-3 |
GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 6.634152e-3 |
GO:0001516 | prostaglandin biosynthetic process | 6.680702e-3 |
GO:0006487 | protein N-linked glycosylation | 6.699420e-3 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 6.768718e-3 |
GO:0051851 | modification by host of symbiont morphology or physiology | 6.773417e-3 |
GO:0048143 | astrocyte activation | 6.797530e-3 |
GO:0051403 | stress-activated MAPK cascade | 6.826698e-3 |
GO:0006659 | phosphatidylserine biosynthetic process | 6.826698e-3 |
GO:2000425 | regulation of apoptotic cell clearance | 6.862494e-3 |
GO:0031328 | positive regulation of cellular biosynthetic process | 6.923346e-3 |
GO:0072112 | glomerular visceral epithelial cell differentiation | 6.964644e-3 |
GO:0001508 | regulation of action potential | 6.998385e-3 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 7.010859e-3 |
GO:0031427 | response to methotrexate | 7.010859e-3 |
GO:0045401 | positive regulation of interleukin-3 biosynthetic process | 7.010859e-3 |
GO:0032092 | positive regulation of protein binding | 7.096523e-3 |
GO:0043491 | protein kinase B signaling cascade | 7.161449e-3 |
GO:2000741 | positive regulation of mesenchymal stem cell differentiation | 7.171206e-3 |
GO:0001678 | cellular glucose homeostasis | 7.199342e-3 |
GO:0033119 | negative regulation of RNA splicing | 7.500391e-3 |
GO:0050905 | neuromuscular process | 7.530405e-3 |
GO:0035640 | exploration behavior | 7.583652e-3 |
GO:0071470 | cellular response to osmotic stress | 7.668251e-3 |
GO:0060689 | cell differentiation involved in salivary gland development | 7.687094e-3 |
GO:0046007 | negative regulation of activated T cell proliferation | 7.687094e-3 |
GO:0044340 | canonical Wnt receptor signaling pathway involved in regulation of cell proliferation | 7.687094e-3 |
GO:0001707 | mesoderm formation | 7.689491e-3 |
GO:0035261 | external genitalia morphogenesis | 7.841484e-3 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 7.862646e-3 |
GO:0002525 | acute inflammatory response to non-antigenic stimulus | 7.862646e-3 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 7.862646e-3 |
GO:0006550 | isoleucine catabolic process | 7.882134e-3 |
GO:0009098 | leucine biosynthetic process | 7.882134e-3 |
GO:0003273 | cell migration involved in endocardial cushion formation | 7.882134e-3 |
GO:0019400 | alditol metabolic process | 7.899648e-3 |
GO:0033233 | regulation of protein sumoylation | 8.035809e-3 |
GO:0045216 | cell-cell junction organization | 8.109469e-3 |
GO:0009891 | positive regulation of biosynthetic process | 8.126267e-3 |
GO:0007369 | gastrulation | 8.131055e-3 |
GO:0010594 | regulation of endothelial cell migration | 8.235400e-3 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 8.258241e-3 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 8.312491e-3 |
GO:0003171 | atrioventricular valve development | 8.367992e-3 |
GO:0048069 | eye pigmentation | 8.391181e-3 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 8.537985e-3 |
GO:0051298 | centrosome duplication | 8.627916e-3 |
GO:0045655 | regulation of monocyte differentiation | 8.647761e-3 |
GO:0048332 | mesoderm morphogenesis | 8.782909e-3 |
GO:0032645 | regulation of granulocyte macrophage colony-stimulating factor production | 8.807007e-3 |
GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport | 8.816764e-3 |
GO:0070483 | detection of hypoxia | 8.816764e-3 |
GO:0007089 | traversing start control point of mitotic cell cycle | 8.816764e-3 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 8.816764e-3 |
GO:0048167 | regulation of synaptic plasticity | 8.830694e-3 |
GO:0034509 | centromeric core chromatin assembly | 8.868603e-3 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 8.868603e-3 |
GO:0008016 | regulation of heart contraction | 9.047490e-3 |
GO:0042335 | cuticle development | 9.054826e-3 |
GO:0070370 | cellular heat acclimation | 9.054826e-3 |
GO:0009794 | regulation of mitotic cell cycle, embryonic | 9.054826e-3 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 9.054826e-3 |
GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9.054826e-3 |
GO:0034589 | hydroxyproline transport | 9.070990e-3 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 9.070990e-3 |
GO:0015826 | threonine transport | 9.070990e-3 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 9.122164e-3 |
GO:0060371 | regulation of atrial cardiomyocyte membrane depolarization | 9.277321e-3 |
GO:0002827 | positive regulation of T-helper 1 type immune response | 9.277321e-3 |
GO:0072655 | establishment of protein localization in mitochondrion | 9.331570e-3 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 9.475851e-3 |
GO:0009913 | epidermal cell differentiation | 9.525691e-3 |
GO:0043270 | positive regulation of ion transport | 9.547614e-3 |
GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 9.724514e-3 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 9.724514e-3 |
GO:2000243 | positive regulation of reproductive process | 9.740822e-3 |
GO:0060088 | auditory receptor cell stereocilium organization | 9.935841e-3 |
GO:0003214 | cardiac left ventricle morphogenesis | 9.978699e-3 |
GO:0033153 | T cell receptor V(D)J recombination | 1.009872e-2 |
GO:0060743 | epithelial cell maturation involved in prostate gland development | 1.011376e-2 |
GO:0002344 | B cell affinity maturation | 1.011376e-2 |
GO:0072092 | ureteric bud invasion | 1.020559e-2 |
GO:0030033 | microvillus assembly | 1.020559e-2 |
GO:0006651 | diacylglycerol biosynthetic process | 1.020559e-2 |
GO:0042026 | protein refolding | 1.026184e-2 |
GO:0001886 | endothelial cell morphogenesis | 1.026184e-2 |
GO:0061004 | pattern specification involved in kidney development | 1.050897e-2 |
GO:0060255 | regulation of macromolecule metabolic process | 1.057593e-2 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 1.071762e-2 |
GO:0006693 | prostaglandin metabolic process | 1.076999e-2 |
GO:0042475 | odontogenesis of dentine-containing tooth | 1.079397e-2 |
GO:0010467 | gene expression | 1.085219e-2 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 1.095696e-2 |
GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.122541e-2 |
GO:0002724 | regulation of T cell cytokine production | 1.140519e-2 |
GO:0002093 | auditory receptor cell morphogenesis | 1.141223e-2 |
GO:0021516 | dorsal spinal cord development | 1.154883e-2 |
GO:0007043 | cell-cell junction assembly | 1.157303e-2 |